Mrs Ryan Denise Gillikin, OT | |
401 Medical Park Dr, Atmore, AL 36502-3006 | |
(251) 368-6346 | |
(251) 368-6255 |
Full Name | Mrs Ryan Denise Gillikin |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 401 Medical Park Dr, Atmore, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295948487 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 2096 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Ryan Denise Gillikin, OT 1102 N White Ave, Bay Minette, AL 36507-3967 Ph: (251) 368-6346 | Mrs Ryan Denise Gillikin, OT 401 Medical Park Dr, Atmore, AL 36502-3006 Ph: (251) 368-6346 |
News Archive
The University of Pittsburgh Medical Center (UPMC) today announced the development of personal health record (PHR) technology that may soon give patients the ability to add critical health information to the electronic health records maintained by hospitals and physicians. UPMC completed the proof-of-concept project in collaboration with Google Health, Carnegie Mellon University (CMU) and technology partner dbMotion.
YM BioSciences Inc. announced today that, in connection with its previously announced public offering for total net proceeds before expenses of US $37,650,000, the underwriters have exercised in full their Over-Allotment Option to purchase an additional 3,750,000 common shares of YM at US $1.60 per share for additional net proceeds of US $5,665,000.
Transplantation of kidneys from Hepatitis C-infected donors to uninfected recipients is safe and can be successfully implemented as a standard of care, according to an observational study by physicians at the University of Tennessee Health Science Center and the James D. Eason Transplant Institute at Methodist University Hospital.
Therapeutics that target lipids called ceramides might hold potential for treating cardiometabolic disease, argues a review article published November 5th in the journal Trends in Pharmacological Sciences.
› Verified 3 days ago